Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

1 results about "Vulvitis" patented technology

Vulvitis is inflammation of the vulva, the external female mammalian genitalia that include the labia majora, labia minora, clitoris, and introitus (the entrance to the vagina). It may co-occur as vulvovaginitis with vaginitis, inflammation of the vagina, and may have infectious or non-infectious causes. The warm and moist conditions of the vulva make it easily affected. Vulvitis is prone to occur in any female especially those who have certain sensitivities, infections, allergies, or diseases that make them likely to have vulvitis. Postmenopausal women and prepubescent girls are more prone to be affected by it, as compared to women in their menstruation period. It is so because they have low estrogen levels which makes their vulvar tissue thin and dry. Women having diabetes are also prone to be affected by vulvitis due to the high sugar content in their cells, increasing their vulnerability. Vulvitis is not a disease, it is just an inflammation caused by an infection, allergy or injury. Vulvitis may also be symptom of any sexually transmitted disease or a fungal infection.

Composition for the improvement, prevention, or treatment of vaginitis or vulvitis, containing Lactobacillus salivarius HHuMin-U

PendingJP2026085246AAntibacterial agentsUnknown materialsLactobacillus salivariusPharmaceutical drug
This invention provides a composition containing Lactobacillus salivarius HHuMin-U (KCCM13001P) for use in improving, preventing, or treating vaginitis or vulvitis. [Solution] A pharmaceutical composition for the prevention or treatment of vaginitis or vulvitis is provided, containing Lactobacillus salivarius HHuMin-U (KCCM13001P) as an active ingredient.
Owner:BIFIDO